Indiana Practice Scenarios & Questions

Question 1

The governor wishes to appoint Sally to the Indiana Board of Pharmacy. Sally was born and raised in Indiana and has been very active in Indiana politics. Currently she resides in Van Wert, Ohio. She has no connection to the pharmacy profession aside from being a consumer. Is Sally eligible to serve as a member of the Board of Pharmacy?

a. No. Sally must be of the same political party as the governor.
b. No. In order to serve on the Board of Pharmacy as a representative of the general public, Sally must reside in Indiana.
c. Yes. Sally meets all the Indiana requirements to serve on the Board of Pharmacy.
d. Yes. Sally need only have been born in Indiana to qualify to serve on the Board of Pharmacy.

Answer 1

b. No. In order to serve on the Board of Pharmacy as a representative of the general public, Sally must reside in Indiana.

Question 2

Alice left the practice of pharmacy to care for her child. Her license has been expired for 2 years and 9 months. She submitted a completed application for renewal and proof of her completed continuing education requirements. The Board of Pharmacy denied her application for reinstatement. Why?

a. Alice failed to complete additional training as required by the Board of Pharmacy.
b. Alice failed to pay the reinstatement fee required by the Board of Pharmacy.
c. Licenses may not be reinstated if they have been lapsed for more than two years.
d. None of the above.

Answer 2

b. Alice failed to pay the reinstatement fee required by the Board of Pharmacy.

Question 3

Pharmacy intern registration is good for:

a. 1 year
b. 2 years
c. 3 years
d. 4 years

Answer 3

a. 1 year

Question 4

John has been a pharmacy technician in the same independent pharmacy for 20 years. John is very familiar with the patients that use the pharmacy. Recently John assisted a patient who was receiving a prescription for Warfarin for the first time. As John handed the medication to the patient, she began asking John questions about the medication’s side effects and why the doctor would have prescribed this medication for her. John answered all of her questions and let her know that she may call him back at the pharmacy to address any additional concerns that she may have about the medication or prescription. Did John violate the law?

a. No. Pharmacy technicians are permitted to address questions at the pharmacy.
b. No. John did not violate the law because he told her that she could call back and ask additional questions.
c. Yes. Only pharmacists may provide drug information to patients.
d. Yes. John is required to provide the patient with written drug information on Warfarin.

Answer 4

c. Yes. Only pharmacists may provide drug information to patients.

Question 5

John, a pharmacy technician, works for Phil, a pharmacist. Three additional pharmacy technicians and two pharmacy technicians in training work for Phil on John’s shift. Phil was recently reviewed by the Board of Pharmacy for his supervisory practices. Has Phil violated Board of Pharmacy rules and regulations?

a. Yes. Phil may only supervise four (4) pharmacy technicians or technicians in training at one time.
b. Yes. Phil may not permit a pharmacy technician to participate in pharmacy technician training programs while working in the pharmacy.
c. No. A pharmacist may supervise as many technicians as is appropriate according to his or her professional judgement.
d. No. Phil may supervise up to six (6) technicians and technicians in training at one time.

Answer 5

d. No. Phil may supervise up to six (6) technicians and technicians in training at one time.

Question 6

Phil wishes to close his pharmacy so that he can move to Florida to retire with his wife. He has submitted the notices as required to the Board of Pharmacy, removed all legend drugs and controlled substances from the premises, met the requirements of the DEA, submitted the premises for inspection by the Board of Pharmacy, and returned his pharmacy permit to the Board of Pharmacy for cancellation. Phil has decided not to sell the building where the pharmacy was and has left the signs Phil’s Drug Shop on the door and above the soda counter as a monument to his long and successful career. Will the Board of Pharmacy approve the closure of Phil’s pharmacy?

a. No. Phil has not paid the closure fee.
b. No. Phil has not removed all the signage from the property.
c. Yes. Phil has fully complied with the law on closure.
d. Yes. Phil only needed to give notice to the Board of Pharmacy and remove the drugs properly close his pharmacy according to Indiana law.

Answer 6

b. No. Phil has not removed all the signage from the property.

Question 7

Drug orders must contain the name, address, and date of birth of the patient.

a. True
b. False

Answer 7

b. False
Required content:
1. Name and bed number of the patient
2. Name and strength or size of the drug or device
3. Unless specified by individual institutional policy or guidelines, the amount to be dispensed either in quantity or days.
4. Adequate directions for the proper use of the drug or device when administered to the patient
5. The name of the prescriber or his designated practitioner

Question 8

Trudy went to the pharmacy to fetch her recently filled prescriptions. The pharmacist asked Trudy if she would like to discuss her prescriptions in compliance with the law’s requirement that pharmacists must offer to counsel patients. The pharmacist noted in Trudy’s electronic file that she declined counseling. The pharmacist maintains all electronic patient files for a minimum of five (5) years. Must the pharmacist maintain a record that Trudy’s choice to decline counseling?

a. Yes, for five (5) years
b. Yes, for two (2) years
c. No, it is optional
d. No, this record is kept by the patient

Answer 8

b. Yes, for two (2) years

Question 9

In a long-term care facility Schedule II controlled substance labeling requirements are not required if no more than a seven day supply is dispensed and the patient does not take control of the drug.

a. True
b. False

Answer 9

a. True

Question 10

Andrew is a first year pharmacist at a new independent pharmacy in Bloomington, Indiana. Andrew is asked by his new boss to administer a shingles immunization to a patient in the pharmacy. May Andrew immunize the patient?

a. Yes. But only if Andrew has had board recognized training on administering immunizations.
b. Yes. Pharmacists may immunize if they are supervised by a prescriber.
c. No.
d. No. Pharmacists must be in practice a minimum of five (5) years to be eligible to immunize patients.

Answer 10

a. Yes. But only if Andrew has had board recognized training on administering immunizations.

Question 11

Tracey is designing her brand new pharmacy facility that she and her partner are building from the ground up. She has designed a large pharmacy dispensing area containing a drive through window, check out counter, and a preparation area for compounding and sterile products preparation. The building will also have a shopping area outside of the pharmacy area with non-pharmacy personnel working in all areas. Her innovative design permits pharmacy staff, technicians, pharmacists, cashiers, and couriers to pass through the compounding area to enter and exit the pharmacy. This facilitates quicker service within the structure of her building. Can Tracey use this design?

a. Yes.
b. Yes. Tracey has ensured prompt service in her design, which is very important.
c. No. The compounding area must be restricted to only those individuals authorized to prepare sterile products and compounds.
d. No. Independent pharmacies may not have drive through windows.

Answer 11

c. No. The compounding area must be restricted to only those individuals authorized to prepare sterile products and compounds.

Question 12

Prescriptions for legend drugs in Indiana are valid for:

a. 90 days
b. 6 months
c. 1 year
d. 2 years

Answer 12

c. 1 year

Question 13

Which of the following statements about Schedule II controlled substances is NOT true:

a. Schedule II controlled substances may not be refilled.
b. Schedule II controlled substances may be partially filled.
c. Schedule II controlled substances must be filed such that they are readily retrievable from other prescriptions.
d. Schedule II controlled substances must be filled within 72 hours of the date prescribed.

Answer 13

d. Schedule II controlled substances must be filed within 72 hours of the date prescribed.

Question 14

Susan, a hospital pharmacist, is responsible for patients in the hospital’s critical care unit. Susan is alerted by a nurse that a patient is having a strange reaction to the medication the nurse administered. Susan reviews the patient’s protocol and finds an error. Susan then develops an alternative drug therapy for the patient. Susan calls the physician and talks with her about this alternative drug therapy. The doctor approves in writing and the nurse changes the patient’s drug regimen. Is this legal?

a. No. The physician must examine the patient before treatment plans are changed.
b. No. Only the prescriber may alter the drug regimen.
c. Yes. A pharmacist may change a drug regimen after reviewing the drug protocol and receiving written authorization from the physician.
d. Yes. The hospital pharmacists may change drug regimen’s of patients without notice to the prescriber as long as it is consistent with the drug protocol.

Answer 14

c. Yes. A pharmacist may change a drug regimen after reviewing the drug protocol and receiving written authorization from the physician.

Question 15

Ricky, a patient, is in his local pharmacy and asks the pharmacist for two (2) convenience packages of cold medicine each containing 60 milligrams of pseudoephedrine for purchase. May Ricky buy this medicine?

a. Yes. But only because it is in convenience packaging.
b. Yes. But only if he signs a log.
c. No. Ricky may not buy more than 60 milligrams of pseudoephedrine in a convenience package in one transaction.
d. No. Ricky may only buy 3.6 grams of pseudoephedrine in one transaction.

Answer 15

c. No. Ricky may not buy more than 60 milligrams of pseudoephedrine in a convenience package in one transaction.

Question 16

Practitioners enrolled in INSPECT must only submit prescriptions for Schedule II, III, and IV controlled substances to the program for monitoring.

a. True
b. False

Answer 16

b. False

Question 17

Jo is a very successful pharmacy entrepreneur. She is currently preparing to open two pharmacies near the teaching hospital in her city. One pharmacy is a compounding pharmacy and the other is an independent pharmacy and ambulatory care clinic. The two pharmacies are connected by a 100-yard underground tunnel. This permits Jo to go back and forth between pharmacies, allowing her to manage both simultaneously since she is the only pharmacist that will be employed. Is this permitted under Indiana law?

a. Yes. But only if Jo can personally approval all prescriptions before dispensing.
b. No. Pharmacies may not have underground access.
c. No. Indiana prohibits adjacent pharmacies from having direct access between them.
d. No. Indiana law prohibits adjacent pharmacies to have the same owner.

Answer 17

c. No. Indiana prohibits adjacent pharmacies from having direct access between them.

Question 18

Indiana requires that records of prescriptions for Schedule II controlled substances must be kept in a separate file from Schedule III, IV, and V prescription records in all pharmacies.

a. True
b. False

Answer 18

b. False

Question 19

The Board of Pharmacy must grant or deny an application, after the application and any additional information required is submitted, for a pharmacy permit within:

a. 30 days
b. 90 days
c. 120 days
d. 1 year

Answer 19

c. 120 days

Question 20

What 7 things must be contained on the label of a filled prescription for a drug in Schedule II according to Indiana law?

Answer 20

1. Date of filling
2. Pharmacy’s name, address, and telephone number
3. Serial number of the prescription
4. Name of the patient
5. Name of the prescribing practitioner
6. Directions for use
7. The cautionary statement “Federal law prohibits the transfer of this drug to any person other than the patient for whom it was prescribed

Question 21

What 7 things must be contained on the label of a filled prescription for drugs in Schedules III and IV according to Indiana law?

Answer 21

1. Date of initial filling
2. Pharmacy name and address
3. Serial number of the prescription
4. Name of the patient
5. Name of the prescribing practitioner
6. Directions for use
7. The cautionary statement “Federal law prohibits the transfer of this drug to any person other than the patient for whom it was prescribed”

Question 22

What 10 things must be labeled on a sterile pharmaceutical product dispensed to a patient according to Indiana law?

Answer 22

1. Date of preparation by the pharmacy
2. Patient’s name and bed number, if an institutionalized patient
3. Name of each drug in the preparation, strength, and amount
4. Expiration date of the preparation, including time, if applicable
5. Identity of the pharmacy compounding and dispensing the sterile pharmaceutical, and identity of other authorized personnel preparing the product, if applicable
6. Other information required by the dispensing pharmacy regarding storage requirements or special warnings
7. Identifying prescription number
8. Prescriber’s full name
9. Name, address, and telephone number of the licensed pharmacy
10. Directions for use shall be provided, either on the label or by other written instructions, including infusion rate and date and time of administration

Question 23

According to federal law, the facsimile of a Schedule II prescription may serve as the original prescription during what three scenarios?

Answer 23

1. A practitioner prescribing a Schedule II narcotic controlled substance to be compounded for the direct administration to a patient by parenteral, intravenous, subcutaneous, or intraspinal infusion may transmit the prescription by facsimile. The pharmacy will consider the facsimile prescription a “written prescription” and no further documentation is required. All normal requirements of a legal prescription must be followed.
2. Practitioners prescribing Schedule II controlled substances for residents of long-term care facilities may transmit a prescription by facsimile to the dispensing pharmacy. The facsimile prescription serves as the original written prescription for the pharmacy. No further documentation is required.
3. A practitioner prescribing a Schedule II narcotic controlled substance for a patient enrolled in a hospice care program certified and/or paid for by Medicare under Title XVIII or a hospice program which is licensed by the state, may transmit a prescription to the dispensing pharmacy by facsimile. The practitioner will note on the prescription that is is for a hospice patient. The facsimile serves as the original written prescription. No further documentation is required.

Question 24

You are the pharmacist working in the evening shift at a local pharmacy. Daniel, a patient you recognize from the pharmacy, presents with a prescription for carisoprodol written by a dentist from the community. Upon questioning, Daniel tells you that he saw his dentist for a checkup earlier today, and after complaining of back pain, received the prescription. Is the prescription valid and should it be filled?

Answer 24

No
In order for a prescription to be valid, it has to satisfy the following stipulations: (1) written for a legitimate medical purpose; and (2) issued in the ordinary course of professional practice. A prescription issued outside of the scope of the prescriber’s professional practice is invalid. In this situation, the prescription is written for a valid condition (back pain), and satisfies the first prong (legitimate medical purposes). However, treating back pain is outside of the dentist’s scope of practice. Therefore, you should not fill the prescription for Daniel.

Question 25

Toward the end of your shift at your pharmacy, a report prints out indicating that you need to order the following controlled substances from the distributor: methylphenidate, tramadol, triazolam, naloxone/buprenorphine, and fentanyl patches. Which of the above medications must be ordered using a DEA form 222?

Answer 25

DEA Form 222 is used to order Schedule I and II controlled substances. Methylphenidate and fentanyl are the only medications that fall into this category (both CII), therefore must be ordered using DEA Form 222. The other medications on the list are CIII-CIV controlled substances.

Question 26

Based on the above question, you would like to order the methylphenidate and fentanyl from the distributor. How is the DEA Form 222 completed, and to where should each copy of the form be sent?

Answer 26

Since you are ordering the medications, the registrant or other person with power of attorney will complete the order form. Your pharmacy keeps copy 3 of the form. You should send copy 1 and 2 to the supplier. The supplier will then forward copy 2 to the DEA.

Question 27

A patient comes to the drop off window during your shift at the pharmacy and hands you a prescription for amphetamine salts 15 mg #90. You examine the prescription to verify its validity and find that it is dated April 21, 2013. Today’s date is June 29, 2013. Can this prescription be legally filled?

Answer 27

The prescription is valid under federal law. According to the federal Controlled Substances Act, amphetamine qualifies as a Schedule II controlled substance. Under federal law, a Schedule II prescription has no expiration date. However, the answer to this question is dependent on state law. Some states have a shorter expiration date for certain medications, including those in Schedule II.

Question 28

Pertaining to the situation on the question above, you are checking your inventory to determine whether you have adequate quantity in stock to fill the patient’s prescription. You find that there are currently only 60 tablets of amphetamine salts 15 mg in stock. You are aware that more tablets were ordered, and will arrive at the pharmacy in 5 days. The patient would like to pick up 60 tablets today and come in for the remainder when the medication arrives. Is this legal?

Answer 28

No
Since this is a prescription for a CII medication, the entire quantity of the prescription must be filled within 72 hours of the initial filling. If the medication is not expected in stock for 5 days, the pharmacy will not be able to fill the remaining 30 tablets within 72 hours. A partial fill can still be dispensed, but a new prescription will be required in order to obtain any additional medication.

Question 29

While checking the controlled substances inventory in your pharmacy, you notice that a bottle of 100 diazepam tablets has gone missing from the previous day. Are you required to report this loss to the DEA?

Answer 29

You are required to report any theft or significant loss of controlled substances to the DEA. If you determine that the medication was not stolen, you must determine if an unexplained loss of 100 tablets of diazepam is significant. You should always err on the side of reporting a loss, and given the quantity missing, and the abuse potential of the product that is missing, you should report this loss using a DEA Form 106. You may also be required to submit a report to the state board of pharmacy or other state pharmacy regulator, as many states have their own laws requiring that controlled substances losses and thefts be reported.

Question 30

Stan presents to your pharmacy with a prescription written for fentanyl patches 25 mcg/h #10. The prescriber, Michael Zoey, has signed and dated the prescription, and has provided the following DEA registration number (MZ3718421). Can this prescription be filled for Stan?

Answer 30

No
The DEA number provided is, on its face, invalid. Verification of the numeric sequence shows that the last digit (the “checking digit”) in the number should be “2.” Remember teh following method for determining the check digit:
Determine the sum of the 1st, 3rd, and 5th digits: 3 + 1 + 4 = 8
Determine the sum of the 2nd, 4th, and 6th digits, and multiply that sum by 2: 7+ 8 + 2 = 17; 17 x 2 = 34
Add those two sums, and the second digit of your answer is the “check digit”: 8 + 34 = 42

Question 31

Stan presents to your pharmacy with a prescription written for fentanyl patches 25 mcg/h #10. The prescriber, Michael Zoey, has signed and dated the prescription, and has provided the following DEA registration number (MZ3718422). Can this prescription be filled for Stan?

Answer 31

The answer to this question is dependent on state law. Although the DEA registration number is numerically valid, it starts with the letter “M” which indicates the prescriber is a mid-level practitioner. Prescriptive authority is decided under state law. If your state permits a mid-level practitioner to prescribe a Schedule II controlled substance that is administered transdermally in the quantity prescribed, and assuming a legitimate medical purpose and a prescription issued in the ordinary course of the prescriber’s professional practice, the answer would be yes.

Question 32

A patient presents to the pharmacy with a new prescription written for Ortho Tri-Cyclen tablets. According to the Poison Prevention Packaging Act, must the pharmacy dispense the medication in a container with a child-proof safety cap?

Answer 32

No

Since Ortho Tri-Cyclen is an oral contraceptive packaged in a “dial-pack,” it is exempt under the PPPA.

Question 33

On a busy Monday afternoon, a patient presents to the pharmacy with a prescription for digoxin 0.125 mg tablets and indicates that he would like to wait for the prescription to be filled. The pharmacy begins to fill the prescription and prints a label for the medication bottle. While verifying the order, the pharmacist fails to notice that the medication placed in the bottle by the technician is actually digoxin 0.25 mg. He dispenses the medication to the patient, labeled as “Digoxin 0.125 mg Tablets.” Is this an example of misbranding, adulteration, both, or neither? Explain.

Answer 33

Misbranding
If the prescription had been dispensed correctly, an ordinary prescription label could be affixed to the prescription bottle, and the misbranding provisions under the FDCA would not apply. However, since the pharmacist dispensed a drug for which no prescription was issued, the misbranding provision do apply, and in this case, the product is misbranded because (1) its labeling is false or misleading (stating that it contains digoxin 0.125 mg, when in fact it contains digoxin 0.25 mg); (2) it fails to contain “adequate directions for use” and adequate warnings.

Question 34

While filling a prescription for Atripla, Betsy, a lead technician at a local pharmacy, drops, a few tablets of the medication on the floor. Realizing that Atripla is an expensive drug, she quickly picks up the tablets, wipes them off on her lab coat, and puts them in the medication bottle. Is this an example of misbranding, adulteration, both, or neither?

Answer 34

Adulteration
According to the FDCA, adulteration occurs if the drug “has been prepared, packed, or held under unsanitary conditions whereby it may have become contaminated with filth, or held under unsanitary conditions whereby it may have become contaminated with filth, or whereby it may have been rendered injurious to health.” Even if the tablets appear fine, the fact that they were dropped on the floor means they “could” have become contaminated and injurious to health. Actual contamination need not be shown.

Question 35

Following the expiration of a patent for the drug Feelgood, Company ABC decides to make the generic version of the drug by filing an Abbreviated New Drug Application (ANDA). What three characteristics of the generic drug must be proven by Company ABC, in order for the ANDA to be approved?

Answer 35

Company ABC must show proof that the generic drug exhibits similar pharmacokinetics, bioavialability, and clinical efficacy as the brand name drug.

Question 36

The manufacturer of a new dietary supplement believes their product will be an inexpensive and highly effective way to lower cholesterol levels. In order to most effectively market the product, the manufacturer includes the following on the label: “Prevents heart disease by lowering cholesterol levels quickly; results seen in just 2 weeks of use.” Knowing that the product is a dietary supplement, the manufacturer is mindful to include the necessary supplemental information stating that “the statements on the label have not been evaluated by the Food and Drug Administration.” Are any laws being violated?

Answer 36

Yes
According to the FDCA, manufacturers of dietary supplements can use “structure-function” claims to promote their products; however, they cannot state that the supplements will treat any conditions. Doing so will force the FDA to consider the supplement to be a “drug,” therefore requiring the submission of a New Drug Application and FDA approval prior to marketing the drug for sale.

Question 37

The manufacturer of a new dietary supplement believes their product will be an inexpensive and highly effective way to lower cholesterol levels. In order to most effectively market the product, the manufacturer includes the following on the label: “Regular use of this product will help maintain normal cholesterol levels.” Knowing that the product is a dietary supplement, the manufacturer is mindful to include the necessary supplemental information stating that “the statements on the label have not been evaluated by the Food and Drug Administration.” Are any laws being violated?

Answer 37

No
The human body produces cholesterol as a normal bodily function. The claim that the product helps maintain healthy cholesterol levels can be fairly construed as a “structure function” claim.

Question 38

John, the owner of a local community pharmacy, has been compounding a certain anti-inflammatory cream for Dr. Smith’s (an area dermatologist) patients for the last 5 years. The compounding of this cream has been a rather lucrative business for John. Recently, a drug manufacturer has started making the same formulation of the cream, making it a commercially available product. Reluctant to lose his profit margin on the compounded formulation, John contacts Dr. Smith and convinces him to slightly alter one of the ingredients in the formulation, so that John can continue to compound the product. Is this in violation of the FDCA?

Answer 38

Yes
First, according to the FDA, a compounding pharmacy is not permitted to routinely compound a commercially available product. Although the pharmacist has persuaded the doctor to change his formulation, it does not appear that the change was medically necessary to treat the patient’s condition. Making such a change simply for profit, is likely to be viewed as violative of the law, and will cause the FDA to treat the pharmacy as a drug manufacturer, and the product as a new drug.

Question 39

According to Indiana law, what 9 pieces of information must be written in ink, indelible ink, typewritten, or electronically written?

Answer 39

1. Full name of the patient
2. Address of the patient
3. Date of issuance
4. Manual or electronic signature of the prescriber
5. Name, address, and license number of the practitioner
6. Federal controlled substance registration number of the practitioner
7. Name, dosage, quantity, and strength of the drug prescribed
8. Refills if appropriate
9. Designation by the practitioner whether the prescription is to be dispensed as written or whether a substitution is permitted

Question 40

What are the 5 pieces of required content on drug orders?

Answer 40

1. The name and bed number of the patient
2. The name and strength or size of the drug or device
3. Unless specified by individual institutional policy or guidelines, the amount to be dispensed either in quantity or days
4. Adequate directions for the proper use of the drug or device when administered to the patient
5. The name of the prescriber or the designated practitioner

Question 41

A pharmacist forgets to dispense a medication guide with a refill of sertraline. The drug is:

a. Adulterated
b. Misbranded
c. Both adulterated and misbranded
d. Neither adulterated or misbranded

Answer 41

b. Misbranded

Question 42

A pharmacist dispenses one box of #12 promethazine 25 mg suppositories from a community pharmacy. Which of the following is accurate regarding a PPI or dispensing in CRC?

a. Do NOT need to provide a PPI and do NOT need to dispense in CRC
b. Must provide a PPI, but NOT dispense in CRC
c. Must dispense in CRC, but NOT provide a PPI
d. Must provide a PPI and must dispense in CRC

Answer 42

a. Do NOT need to provide a PPI and do NOT need to dispense in CRC

Question 43

The Prescription Drug Marketing Act:

a. Prohibits the distribution of OTC samples to retail pharmacies
b. Allows pharmacies to sell starter packs that contain small quantities of drug product intended to initiate patient therapy
c. Allows hospitals to resell drug products purchased by the hospital at discounted prices to community pharmacies at marked-up prices
d. 1 and 2
e. All of the above

Answer 43

b. Allows pharmacies to sell starter packs that contain small quantities of drug product intended to initiate patient therapy

Question 44

OTC drugs that are not packaged in tamper-resistant packaging, as required by regulations, may be considered to be:

a. Adulterated
b. Misbranded
c. Both adulterated and misbranded
d. Neither adulterated or misbranded

Answer 44

c. Both adulterated and misbranded

Question 45

A pharmacy must include which of the following items on its controlled substance inventory record?

a. Signature of the person or persons taking the inventory
b. Name, address, and DEA registration number of the registrant
c. Date of inventory
d. The time the inventory was taken (“opening of business” or “close of business”)
e. All of the above

Answer 45

e. All of the above

Question 46

After proper verification, a pharmacist may choose to fill an acetaminophen with codeine prescription issued by an authorized prescriber in any of the following locations except:

a. Hawaii
b. Guam
c. Puerto Rico
d. Canada
e. US Virgin Islands

Answer 46

d. Canada

Question 47

If a tramadol 50 mg prescription had directions “1 BID x 14 days” without a quantity how many tablets would you dispense?

a. 0
b. 14
c. 28

Answer 47

a. 0

Question 48

A prescription was written for Kapvay 0.1 mg for a patient on Indiana Medicaid. The prescriber signed dispense as written but no other notation was on the prescription. The patient wants brand. You must:

a. Dispense brand - the prescription was signed DAW
b. Dispense brand - the patient requested brand
c. Dispense generic - this would not meet the requirements to dispense brand
d. Dispense generic - Indiana law requires all prescriptions are generic

Answer 48

c. Dispense generic - this would not meet the requirements to dispense brand

Question 49

A pharmacy has a policy in place to refuse to fill a particular prescriber’s prescriptions. This falls into the pharmacist refusal provisions.

a. True
b. False

Answer 49

b. False

Question 50

Which of the following is the correct number of CE hours a pharmacist reciprocating their license to Indiana on July 1, 2020 must complete?

a. 0
b. 7.5
c. 22.5
d. 30

Answer 50

d. 30